Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.

Wang G, Li Y, Xiong C, Benzinger TLS, Gordon BA, Hassenstab J, Aschenbrenner AJ, McDade E, Clifford DB, Libre-Guerra JJ, Shi X, Mummery CJ, van Dyck CH, Lah JJ, Honig LS, Day G, Ringman JM, Brooks WS, Fox NC, Suzuki K, Levin J, Jucker M, Delmar P, Bittner T, Bateman RJ, DIAN‐TU Study Team

Open source

DOI: 10.1002/alz.13735
Published: 2024 Apr
Container: Alzheimer's & dementia : the journal of the Alzheimer's Association
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/alz.13735,
  title = {Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.},
  author = {Wang G and Li Y and Xiong C and Benzinger TLS and Gordon BA and Hassenstab J and Aschenbrenner AJ and McDade E and Clifford DB and Libre-Guerra JJ and Shi X and Mummery CJ and van Dyck CH and Lah JJ and Honig LS and Day G and Ringman JM and Brooks WS and Fox NC and Suzuki K and Levin J and Jucker M and Delmar P and Bittner T and Bateman RJ and DIAN‐TU Study Team},
  year = {2024},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  doi = {10.1002/alz.13735},
  url = {https://doi.org/10.1002/alz.13735}
}

RIS

TY  - JOUR
TI  - Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.
AU  - Wang G
AU  - Li Y
AU  - Xiong C
AU  - Benzinger TLS
AU  - Gordon BA
AU  - Hassenstab J
AU  - Aschenbrenner AJ
AU  - McDade E
AU  - Clifford DB
AU  - Libre-Guerra JJ
AU  - Shi X
AU  - Mummery CJ
AU  - van Dyck CH
AU  - Lah JJ
AU  - Honig LS
AU  - Day G
AU  - Ringman JM
AU  - Brooks WS
AU  - Fox NC
AU  - Suzuki K
AU  - Levin J
AU  - Jucker M
AU  - Delmar P
AU  - Bittner T
AU  - Bateman RJ
AU  - DIAN‐TU Study Team
PY  - 2024
JO  - Alzheimer's & dementia : the journal of the Alzheimer's Association
DO  - 10.1002/alz.13735
UR  - https://doi.org/10.1002/alz.13735
ER  -

APA

G, W., Y, L., C, X., TLS, B., BA, G., J, H., AJ, A., E, M., DB, C., JJ, L., X, S., CJ, M., CH, V. D., JJ, L., LS, H., G, D., JM, R., WS, B., NC, F., K, S., J, L., M, J., P, D., T, B., RJ, B., & Team, D. S. (2024). Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.13735

Source records

pubmed · retrieved 2026-09-26T01:49:02.280Z